Meridiem Capital Partners LP Edwards Lifesciences Corp Transaction History
Meridiem Capital Partners LP
- $1.14 Trillion
- Q4 2024
A detailed history of Meridiem Capital Partners LP transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Meridiem Capital Partners LP holds 42,843 shares of EW stock, worth $3.2 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
42,843Holding current value
$3.2 Million% of portfolio
0.28%Shares
1 transactions
Others Institutions Holding EW
# of Institutions
1,377Shares Held
485MCall Options Held
6.71MPut Options Held
3.17M-
Vanguard Group Inc Valley Forge, PA69.1MShares$5.16 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY51MShares$3.81 Billion0.11% of portfolio
-
Wellington Management Group LLP Boston, MA33.2MShares$2.48 Billion0.46% of portfolio
-
State Street Corp Boston, MA25.8MShares$1.93 Billion0.08% of portfolio
-
Jpmorgan Chase & CO New York, NY14.9MShares$1.11 Billion0.09% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $46.2B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...